May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Sub-Threshold Infrared Micro Pulsed Laser Treatment for Chronic Central Serous Choroidopathy
Author Affiliations & Notes
  • A. R. Dare
    Ophthalmology, Sch of Med Ribeirao Preto-USP, Ribeirao Preto, Brazil
  • J. A. Cardillo
    Ophthalmology, Hospital, Araraquara, Brazil, Araraquara, Brazil
  • F. Tognin
    Ophthalmology, Hospital, Araraquara, Brazil, Araraquara, Brazil
  • Footnotes
    Commercial Relationships  A.R. Dare, None; J.A. Cardillo, None; F. Tognin, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 4718. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. R. Dare, J. A. Cardillo, F. Tognin; Sub-Threshold Infrared Micro Pulsed Laser Treatment for Chronic Central Serous Choroidopathy. Invest. Ophthalmol. Vis. Sci. 2008;49(13):4718. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the potential of a sub-threshold, short pulsed, 810-nm diode laser for the treatment of chronic choroidopathy serous central.

Methods: : Five patients with chronic signals of central serous choroidopathy were treated. Following adjustment for individual chorioretinal pigmentation, micro pulsed laser envelopes of 180 µs (totalizing 300ms) in confluent spots were delivered to the pinpoint leakage in order to obtaining a security margin of 200 µm. For main outcome measures changes in ETDRS best correct visual acuity and central macular thickness obtained using optical coherence tomography were series-measured over a 6-months follow-up. Pre and post-treatment fluorescein angiography (FA) were evaluated.

Results: : No visible signs of treatment could be detected either on the eye fundus examination or FA. Improvement of 2 to 3 lines on the ETDRS chart was achieved in all patients. Exams demonstrated decreased exudation on fluorescein angiography, optical coherence tomography, and/or clinical examination. Central macular thickness decreased from a mean of 445 µm to 297 µm after 3 months of treatment. No procedure related side effects were observed.

Keywords: retina • laser • macula/fovea 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×